Amlodipine Besylate Tablet
Product Images NDC 69584-022

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 69584-022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oxford Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mg Label

Label for Amlodipine Besylate Tablets, USP 10 mg by Oxford Pharmaceuticals, LLC. The label displays the NDC 69584-023-90 and notes the package contains 1000 tablets. It includes storage instructions, pharmacist dispensing information, and a patient information sheet URL. The label features the Oxford Pharmaceuticals logo and manufacturing details.*

FDA Label Image

2.5mg Label

Label for Amlodipine Besylate Tablets USP 2.5 mg by Oxford Pharmaceuticals, LLC. The label includes dosage strength, quantity of 1000 tablets, directions to print patient information from a specified website, and storage instructions to store at 20° to 25°C. The label also displays the NDC code 69584-021-90 and a barcode.*

FDA Label Image

5mg Label

Label for Amlodipine Besylate Tablets USP 5 mg by Oxford Pharmaceuticals, LLC. The label includes the National Drug Code 69584-022-90, indicates the package contains 1000 tablets, and advises to dispense with patient information sheet. Storage instructions specify 20° to 25°C (68° to 77°F) and protection from light. The label includes a barcode and serialization area.*

FDA Label Image

Figure-1 (Figure1)

A Kaplan-Meier survival curve chart showing event rate over 24 months comparing Amlodipine and Placebo groups. The chart includes a p-value, hazard ratio, and confidence interval, with time in months on the x-axis and event rate on the y-axis. The number of subjects at risk is displayed below the x-axis at various time points.*

FDA Label Image

Figure-2 (Figure2)

A forest plot displaying hazard ratios and 95% confidence intervals comparing Amlodipine to placebo across various patient subgroups, including overall patients, age groups (<65, >=65), gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. The x-axis represents hazard ratios from 0.0 to 2.0, indicating whether results favor Amlodipine or placebo.*

FDA Label Image

Structure (Structure)

Chemical structure of amlodipine besylate, the active ingredient in AMLODIPINE BESYLATE 5 mg oral tablets by Oxford Pharmaceuticals, LLC. The diagram shows the molecular arrangement including chlorine (Cl), oxygen (O), nitrogen (N), and other atoms forming the complete chemical compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.